BB&T Corp increased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 32.2% during the second quarter, according to its most recent filing with the SEC. The fund owned 14,961 shares of the medical instruments supplier’s stock after buying an additional 3,642 shares during the period. BB&T Corp’s holdings in DENTSPLY SIRONA were worth $970,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the company. Ropes Wealth Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 0.3% in the first quarter. Ropes Wealth Advisors LLC now owns 9,003 shares of the medical instruments supplier’s stock valued at $562,000 after buying an additional 29 shares in the last quarter. HighTower Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 0.6% in the first quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock valued at $424,000 after buying an additional 39 shares in the last quarter. Atria Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 1.5% in the second quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock valued at $294,000 after buying an additional 68 shares in the last quarter. Creative Planning boosted its stake in shares of DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock valued at $425,000 after buying an additional 70 shares in the last quarter. Finally, Northwest Wealth Management LLC boosted its stake in shares of DENTSPLY SIRONA by 1.4% in the first quarter. Northwest Wealth Management LLC now owns 5,834 shares of the medical instruments supplier’s stock valued at $364,000 after buying an additional 80 shares in the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.
Shares of DENTSPLY SIRONA Inc. (XRAY) traded down 1.49% during trading on Tuesday, hitting $61.41. 2,044,255 shares of the stock traded hands. DENTSPLY SIRONA Inc. has a 12 month low of $55.00 and a 12 month high of $65.68. The company has a 50 day moving average price of $63.70 and a 200 day moving average price of $62.23. The firm has a market cap of $14.08 billion, a price-to-earnings ratio of 39.52 and a beta of 1.26.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by $0.01. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. The company had revenue of $900.50 million during the quarter, compared to the consensus estimate of $916.55 million. During the same quarter in the prior year, the firm earned $0.69 earnings per share. The business’s revenue was up 16.6% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.57%. DENTSPLY SIRONA’s dividend payout ratio is presently 22.58%.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by BBNS and is the property of of BBNS. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://baseballnewssource.com/markets/dentsply-sirona-inc-nasdaqxray-shares-bought-by-bbt-corp-updated/1313154.html.
XRAY has been the topic of several analyst reports. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Finally, HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $67.92.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with our FREE daily email newsletter.